Related Articles
KRAS and BRAF mutations in serum exosomes from patients with colorectal cancer in a Chinese population
Molecular alterations in clinical stageĀ III cutaneous melanoma: Correlation with clinicopathological features and patient outcome
Dysregulation of KRAS signaling in pancreatic cancer is not associated with KRAS mutations and outcome
Genetic alterations in lung adenocarcinoma with a micropapillary component
EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas